Skip to main content
Top
Published in: Diabetologia 3/2007

01-03-2007 | Article

Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women

Authors: D. Gordin, V. Hiilesmaa, J. Fagerudd, M. Rönnback, C. Forsblom, R. Kaaja, K. Teramo, P.-H. Groop, FinnDiane Study Group

Published in: Diabetologia | Issue 3/2007

Login to get access

Abstract

Aims/hypothesis

Our aim was to study whether pre-eclampsia and pregnancy-induced hypertension are predictors of diabetic nephropathy in type 1 diabetic women.

Materials and methods

A total of 203 type 1 diabetic women, who were pregnant between 1988 and 1996 and followed at the Department of Obstetrics and Gynaecology in Helsinki, were re-assessed after an average of 11 years within the nationwide, multi-centre Finnish Diabetic Nephropathy Study. Diabetic nephropathy was defined as microalbuminuria, macroalbuminuria or end-stage renal disease.

Results

Patients with prior pre-eclampsia had diabetic nephropathy more often than patients with a normotensive pregnancy (diabetic nephropathy vs normal albumin excretion rate: 41.9% vs 8.9%; p<0.001), whereas patients with a history of pregnancy-induced hypertension did not (10.3% vs 8.9%; p=0.81). CHD was more prevalent in patients with a history of pre-eclampsia than in patients with a normotensive pregnancy (12.2% vs. 2.2%; p=0.03). Pre-eclampsia (odds ratio [OR] 7.7, 95% CI 1.6-36.1; p=0.01) and HbA1c (OR 2.0, 95% CI 1.1-3.8; p<0.05) were associated with incident diabetic nephropathy even when adjusted for follow-up time, BMI, smoking, diabetes duration and age.

Conclusions/interpretation

These data suggest that a history of pre-eclamptic pregnancy but not pregnancy-induced hypertension is associated with an elevated risk of diabetic nephropathy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592–1594PubMedCrossRef Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592–1594PubMedCrossRef
2.
3.
go back to reference Chambers J, Fusi L, Malik I, Haskard D, De Swiet M, Kooner J (2001) Association of maternal endothelial dysfunction with preeclampsia. JAMA 285:1607–1612PubMedCrossRef Chambers J, Fusi L, Malik I, Haskard D, De Swiet M, Kooner J (2001) Association of maternal endothelial dysfunction with preeclampsia. JAMA 285:1607–1612PubMedCrossRef
5.
go back to reference Ewers IM, de Valk HW, Visser GHA (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Br Med J 328:915–921CrossRef Ewers IM, de Valk HW, Visser GHA (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Br Med J 328:915–921CrossRef
6.
go back to reference Hiilesmaa V, Suhonen L, Teramo K (2000) Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 43:1534–1539PubMedCrossRef Hiilesmaa V, Suhonen L, Teramo K (2000) Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 43:1534–1539PubMedCrossRef
7.
go back to reference Combs CA, Rosenn B, Kitzmiller JL, Khoury JC, Wheeler BC, Miodovnik M (1993) Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 82:802–807PubMed Combs CA, Rosenn B, Kitzmiller JL, Khoury JC, Wheeler BC, Miodovnik M (1993) Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 82:802–807PubMed
8.
go back to reference Sibai BM, Caritis S, Hauth J et al (2000) Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National institute of child health and human development network of maternal-fetal medicine units. Am J Obstet Gynecol 182:364–369PubMedCrossRef Sibai BM, Caritis S, Hauth J et al (2000) Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National institute of child health and human development network of maternal-fetal medicine units. Am J Obstet Gynecol 182:364–369PubMedCrossRef
9.
go back to reference Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Molvig J, Mathiesen ER (2001) Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 24:1739–1744PubMed Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Molvig J, Mathiesen ER (2001) Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 24:1739–1744PubMed
10.
go back to reference Hanson U, Persson B (1998) Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 77:620–624PubMedCrossRef Hanson U, Persson B (1998) Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 77:620–624PubMedCrossRef
11.
go back to reference Lampinen KH, Rönnback M, Kaaja RJ, Groop PH (2006) Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 24:751–756PubMedCrossRef Lampinen KH, Rönnback M, Kaaja RJ, Groop PH (2006) Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 24:751–756PubMedCrossRef
12.
go back to reference Irgens HU, Reisaeter L, Irgens LM, Lie RT (2001) Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 7323:1213–1217CrossRef Irgens HU, Reisaeter L, Irgens LM, Lie RT (2001) Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 7323:1213–1217CrossRef
13.
go back to reference Hannaford P, Ferry S, Hirsch S (1997) Cardiovascular sequelae of toxaemia of pregnancy. Heart 2:154–158 Hannaford P, Ferry S, Hirsch S (1997) Cardiovascular sequelae of toxaemia of pregnancy. Heart 2:154–158
14.
go back to reference Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R (2004) Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 6:805–808CrossRef Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R (2004) Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 6:805–808CrossRef
15.
go back to reference Kaaja R, Sjöberg L, Hellsted T, Immonen I, Sane T, Teramo K (1996) Long-term effects of pregnancy on diabetic complications. Diabet Med 13:165–169PubMedCrossRef Kaaja R, Sjöberg L, Hellsted T, Immonen I, Sane T, Teramo K (1996) Long-term effects of pregnancy on diabetic complications. Diabet Med 13:165–169PubMedCrossRef
16.
go back to reference Lovestam-Adrian M, Agardh CD, Aberg A, Agardh E (1997) Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type 1 diabetic patients. Diabet Med 14:1059–1065PubMedCrossRef Lovestam-Adrian M, Agardh CD, Aberg A, Agardh E (1997) Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type 1 diabetic patients. Diabet Med 14:1059–1065PubMedCrossRef
17.
go back to reference Miodovnik M, Rosenn BM, Khoury JC, Grigsby JL, Siddiqi TA (1996) Does pregnancy increase the risk for development and progression of diabetic nephropathy? Am J Obstet Gynecol 174:1180–1189PubMedCrossRef Miodovnik M, Rosenn BM, Khoury JC, Grigsby JL, Siddiqi TA (1996) Does pregnancy increase the risk for development and progression of diabetic nephropathy? Am J Obstet Gynecol 174:1180–1189PubMedCrossRef
18.
go back to reference Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93PubMedCrossRef Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93PubMedCrossRef
19.
go back to reference Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430–1432PubMedCrossRef Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430–1432PubMedCrossRef
20.
go back to reference Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type 1 diabetes. Am J Med 78:785–794PubMedCrossRef Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type 1 diabetes. Am J Med 78:785–794PubMedCrossRef
21.
go back to reference Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501PubMedCrossRef Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501PubMedCrossRef
22.
go back to reference Stehouwer C, Gall M, Twisk J, Knudsen E, Emeis J (1997) Endothelial dysfunction and the pathogenesis of diabetic angiopathy. Cardiovasc Res 34:55–68PubMedCrossRef Stehouwer C, Gall M, Twisk J, Knudsen E, Emeis J (1997) Endothelial dysfunction and the pathogenesis of diabetic angiopathy. Cardiovasc Res 34:55–68PubMedCrossRef
23.
go back to reference Rossing P, Hougaard P, Parving H-H (2002) Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25:859–864PubMed Rossing P, Hougaard P, Parving H-H (2002) Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25:859–864PubMed
24.
go back to reference Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS (2001) A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 50:2842–2849PubMed Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS (2001) A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 50:2842–2849PubMed
25.
go back to reference Caritis S, Sibai B, Hauth J et al (1998) Predictors of pre-eclampsia in women at high risk. National institute of child health and human development network of maternal-fetal medicine units. Am J Obst Gynecol 4:946–951CrossRef Caritis S, Sibai B, Hauth J et al (1998) Predictors of pre-eclampsia in women at high risk. National institute of child health and human development network of maternal-fetal medicine units. Am J Obst Gynecol 4:946–951CrossRef
26.
go back to reference Levine RJ, Ewell MG, Hauth JC et al (2000) Should the definition of preeclampsia include a rise in diastolic blood pressure of ≥15 mm Hg to a level <90 mm Hg in association with proteinuria? Am J Obst Gynecol 183:787–792CrossRef Levine RJ, Ewell MG, Hauth JC et al (2000) Should the definition of preeclampsia include a rise in diastolic blood pressure of ≥15 mm Hg to a level <90 mm Hg in association with proteinuria? Am J Obst Gynecol 183:787–792CrossRef
27.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obst Gynecol 183:S1–S22 National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obst Gynecol 183:S1–S22
28.
go back to reference Forsblom CM, Groop P-H, Ekstrand A, Groop L (1992) Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. Br Med J 305:1051–1053CrossRef Forsblom CM, Groop P-H, Ekstrand A, Groop L (1992) Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. Br Med J 305:1051–1053CrossRef
29.
go back to reference Rudge MV, Calderon IM, Ramos MD, Peracoli JC, Pim A (1997) Hypertensive disorders in pregnant women with diabetes mellitus. Gynecol Obstet Invest 44:11–15PubMedCrossRef Rudge MV, Calderon IM, Ramos MD, Peracoli JC, Pim A (1997) Hypertensive disorders in pregnant women with diabetes mellitus. Gynecol Obstet Invest 44:11–15PubMedCrossRef
30.
go back to reference Lampinen K, Rönnback M, Groop P-H, Kaaja R (2006) Renal and vascular function in women with previous preeclampsia: a comparison of low- and high-degree proteinuria. Kidney Int 70:1818–1822PubMedCrossRef Lampinen K, Rönnback M, Groop P-H, Kaaja R (2006) Renal and vascular function in women with previous preeclampsia: a comparison of low- and high-degree proteinuria. Kidney Int 70:1818–1822PubMedCrossRef
31.
go back to reference Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obst Gynecol 161:1200–1204 Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obst Gynecol 161:1200–1204
32.
go back to reference Luppi P, Deloia JP (2006) Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 118:268–275PubMedCrossRef Luppi P, Deloia JP (2006) Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 118:268–275PubMedCrossRef
33.
go back to reference Saraheimo M, Forsblom C, Hansen TK et al; FinnDiane Study Group (2005) Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 48:198–202PubMedCrossRef Saraheimo M, Forsblom C, Hansen TK et al; FinnDiane Study Group (2005) Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 48:198–202PubMedCrossRef
34.
go back to reference Spargo BH, McCartney CP, Winemiller R (1959) Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol 68:593–599PubMed Spargo BH, McCartney CP, Winemiller R (1959) Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol 68:593–599PubMed
35.
go back to reference Gärtner HV, Sammoun A, Wehrmann M, Grossmann T, Junghans R, Weihing C (1998) Preeclamptic nephropathy—an endothelial lesion. A morphological study with a review of the literature. Eur J Obstet Gynaecol 77:11–27CrossRef Gärtner HV, Sammoun A, Wehrmann M, Grossmann T, Junghans R, Weihing C (1998) Preeclamptic nephropathy—an endothelial lesion. A morphological study with a review of the literature. Eur J Obstet Gynaecol 77:11–27CrossRef
36.
go back to reference Österby R (1992) Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35:803–812PubMedCrossRef Österby R (1992) Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35:803–812PubMedCrossRef
37.
go back to reference Arngrimsson R, Bjornsson S, Gersson RT, Bjornsson II, Walker JJ, Snaedal G (1990) Genetic and familial predisposition to eclampsia and preeclampsia in a defined population. Br J Obstet Gynaecol 97:131–140 Arngrimsson R, Bjornsson S, Gersson RT, Bjornsson II, Walker JJ, Snaedal G (1990) Genetic and familial predisposition to eclampsia and preeclampsia in a defined population. Br J Obstet Gynaecol 97:131–140
38.
go back to reference Cooper DW, Brennecke SP, Wilton AN (1993) Genetics of preclampsia. Hypertens Pregnancy 12:1–23 Cooper DW, Brennecke SP, Wilton AN (1993) Genetics of preclampsia. Hypertens Pregnancy 12:1–23
39.
go back to reference Deckert T, Feldt-Rasmussen K, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219–226PubMedCrossRef Deckert T, Feldt-Rasmussen K, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219–226PubMedCrossRef
40.
41.
go back to reference Kaaja R, Sjöberg L, Hellstedt T, Immonen I, Sane T, Teramo K (1996) Long-term effects of pregnancy on diabetic complications. Diabet Med 13:165–169PubMedCrossRef Kaaja R, Sjöberg L, Hellstedt T, Immonen I, Sane T, Teramo K (1996) Long-term effects of pregnancy on diabetic complications. Diabet Med 13:165–169PubMedCrossRef
42.
go back to reference Chaturvedi N, Stephenson JM, Fuller JH (1995) The relationship between pregnancy and long-term maternal complications in the EURODIAB IDDM Complications Study. Diabet Med 12:494–499PubMedCrossRef Chaturvedi N, Stephenson JM, Fuller JH (1995) The relationship between pregnancy and long-term maternal complications in the EURODIAB IDDM Complications Study. Diabet Med 12:494–499PubMedCrossRef
43.
go back to reference Purdy LP, Hantsch CE, Molitch ME et al (1996) Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 19:1067–1076PubMed Purdy LP, Hantsch CE, Molitch ME et al (1996) Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 19:1067–1076PubMed
Metadata
Title
Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women
Authors
D. Gordin
V. Hiilesmaa
J. Fagerudd
M. Rönnback
C. Forsblom
R. Kaaja
K. Teramo
P.-H. Groop
FinnDiane Study Group
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0544-5

Other articles of this Issue 3/2007

Diabetologia 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.